{"schema_version":"1","generated_at":"2026-10-29T13:53:48.929Z","data_as_of":"2026-10-23","url":"https://www.findmykol.com/kol/lilie-lin","json_url":"https://www.findmykol.com/kol/lilie-lin/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"lilie-lin","name":"Lilie Lin","credential":"MD","title":"Professor, Radiation Oncology","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Gynecologic","therapeutic_areas":["Gynecologic"],"institution":"The University of Texas MD Anderson Cancer Center","institution_url":"https://www.findmykol.com/institution/the-university-of-texas-md-anderson-cancer-center","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1831283340","orcid":"0000-0001-7681-8966","openalex":"A5034744116"},"summary":"Lilie Lin is Professor, Radiation Oncology at The University of Texas MD Anderson Cancer Center. OpenAlex indexes 256 publications with 4,057 citations (h-index 34); ClinicalTrials.gov lists 13 registered studies with this person as an investigator.","overview":{"text":"Lilie Lin, MD, is Professor, Radiation Oncology at The University of Texas MD Anderson Cancer Center. The public record shows 256 publications with 4,057 citations (h-index 34), centered on Endometrial and Cervical Cancer Treatments, Medical Imaging Techniques and Applications, Radiopharmaceutical Chemistry and Applications. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 4 companies, 2 NIH-funded awards (2021–2026).","bullets":["Most recent indexed publication: 2026 · JCO global oncology","Top research focus: Endometrial and Cervical Cancer Treatments","13 registered trials on ClinicalTrials.gov","Open Payments reporting from 4 companies"],"generated_at":"2026-10-28"},"focus":{"indications":[{"label":"Uterine Cervical Neoplasms","therapeutic_area":"Oncology","trials":4,"topics":0,"strength":12},{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Endometrial Neoplasms","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Vulvar Neoplasms","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Vaginal Neoplasms","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Coma","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Neoplasm Metastasis","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Brain Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Carcinoma, Squamous Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Papilloma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Prostate Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Fallopian Tube Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3}],"research_topics":["Endometrial and Cervical Cancer Treatments","Medical Imaging Techniques and Applications","Radiopharmaceutical Chemistry and Applications","PARP inhibition in cancer therapy","Cervical Cancer and HPV Research"],"drugs_studied":{"total":2,"shown":2,"withheld":0,"rows":[{"name":"Lynparza","generic":"Olaparib","trials":0,"payments":1,"publications":1,"mentions":2},{"name":"Gozetotide","trials":0,"payments":2,"publications":0,"mentions":2}]},"works_with":{"total":8,"shown":3,"withheld":5,"rows":[{"name":"Abramson Cancer Center at Penn Medicine","trials":6,"payments":0,"mentions":6},{"name":"M.D. Anderson Cancer Center","trials":5,"payments":0,"mentions":5},{"name":"AstraZeneca Pharmaceuticals LP","trials":0,"payments":1,"mentions":1}]}},"scholarship":{"works_count":256,"cited_by_count":4057,"h_index":34,"i10_index":72,"pubmed_count":13,"latest_activity_year":2026,"source":"works"},"trials":{"count":13,"shown":3,"withheld":10,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07723651","title":"[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)","phase":"PHASE2","status":"NOT_YET_RECRUITING","role":"Investigator","sponsor":"Washington University School of Medicine","source_url":"https://clinicaltrials.gov/study/NCT07723651","trial_url":"https://www.findmykol.com/trial/NCT07723651"},{"nct":"NCT04634617","title":"Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors","status":"ACTIVE_NOT_RECRUITING","role":"Investigator","sponsor":"M.D. Anderson Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT04634617","trial_url":"https://www.findmykol.com/trial/NCT04634617"},{"nct":"NCT04169763","title":"Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery","phase":"PHASE1","status":"RECRUITING","role":"Investigator","sponsor":"M.D. Anderson Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT04169763","trial_url":"https://www.findmykol.com/trial/NCT04169763"}],"source":"trials"},"payments":{"company_count":4,"program_years":{"first":2023,"last":2024},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"Merck Sharp & Dohme LLC","program_year":2024,"amount_usd":2135,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1831283340"},{"payer":"Elekta, Inc.","program_year":2023,"amount_usd":133.16,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1831283340"},{"payer":"Telix Pharmaceuticals","program_year":2023,"amount_usd":128.48,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1831283340"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1831283340","source":"payments"},"funding":{"award_count":2,"fiscal_years":{"first":2021,"last":2026},"rows_total":16,"shown":3,"withheld":13,"rows":[{"project":"R01CA284623","title":"The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia","fiscal_year":2026,"amount_usd":663372,"organization":"UNIVERSITY OF TX MD ANDERSON CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/R01CA284623"},{"project":"R01CA284623","title":"The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia","fiscal_year":2026,"amount_usd":68809,"organization":"UNIVERSITY OF TX MD ANDERSON CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/R01CA284623"},{"project":"R01CA284623","title":"The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia","fiscal_year":2026,"amount_usd":27996,"organization":"UNIVERSITY OF TX MD ANDERSON CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/R01CA284623"}],"source":"grants"},"congress":{"count":43,"years":{"first":2004,"last":2025},"societies":["AACR","ASCO","ASTRO"],"shown":3,"withheld":40,"rows":[{"title":"Management of De-Novo Stage IVB Cervical Cancer with Induction Chemotherapy Followed by Definitive Chemoradiation","society":"ASTRO","meeting":"ASTRO Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.ijrobp.2025.06.2332","source_url":"https://doi.org/10.1016/j.ijrobp.2025.06.2332","status":"verified"},{"title":"Outcomes of Patients with Gastric-Type Adenocarcinoma of the Uterine Cervix after Definitive or Adjuvant Chemoradiotherapy","society":"ASTRO","meeting":"ASTRO Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.ijrobp.2025.06.2279","source_url":"https://doi.org/10.1016/j.ijrobp.2025.06.2279","status":"verified"},{"title":"The impact of HIV and CD4 count stratification on all cause mortality for adenocarcinoma and squamous cell lung cancers in the antiretroviral therapy era: Analysis of National Veterans Affairs and Kaiser Permanente Northern cohorts.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2024,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.8070","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.8070","status":"verified"}],"source":"congress"},"publications":{"total":13,"shown":5,"withheld":8,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Artificial Intelligence-Powered Radiotherapy for Resource-Limited Settings: Advancing Cervical and Prostate Cancer Treatment Planning With the Radiation Planning Assistant.","year":2026,"journal":"JCO global oncology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42424567/","status":"verified"},{"title":"Baseline PARP-1 PET imaging in patients with advanced solid tumors with DNA damage response mutations.","year":2026,"journal":"European journal of nuclear medicine and molecular imaging","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41251745/","status":"verified"},{"title":"Use of Interactive, Patient-Centric Mobile Health Technology in Sub-Saharan Africa: A Scoping Review.","year":2025,"journal":"JCO global oncology","types":["Journal Article","Scoping Review","Research Support, N.I.H., Extramural"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40768687/","status":"verified"},{"title":"Cervical cancer treatment outcomes and survival in Botswana by human immunodeficiency virus status: Ipabalele study results.","year":2025,"journal":"JNCI cancer spectrum","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40342166/","status":"verified"},{"title":"Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Patients with Cervical Cancer Undergoing Definitive Chemoradiation.","year":2025,"journal":"Clinical cancer research : an official journal of the American Association for Cancer Research","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/39680029/","status":"verified"}],"most_cited":{"total":256,"shown":5,"withheld":251,"rows":[{"title":"Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline","year":2020,"cited_by_count":315,"type":"article","source_url":"https://doi.org/10.1016/j.prro.2020.04.002"},{"title":"Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring","year":2023,"cited_by_count":271,"type":"article","source_url":"https://doi.org/10.1016/j.ccell.2023.09.012"},{"title":"HIV Infection and Survival Among Women With Cervical Cancer","year":2016,"cited_by_count":202,"type":"article","source_url":"https://doi.org/10.1200/jco.2016.67.9613"},{"title":"Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: A SEER analysis","year":2008,"cited_by_count":160,"type":"article","source_url":"https://doi.org/10.1016/j.ygyno.2008.05.016"},{"title":"A Systematic Review of Radiotherapy Capacity in Low- and Middle-Income Countries","year":2015,"cited_by_count":158,"type":"review","source_url":"https://doi.org/10.3389/fonc.2014.00380"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Anuja Jhingran","coauthored_works":71,"profile_url":"https://www.findmykol.com/kol/anuja-jhingran"},{"name":"Ann H. Klopp","coauthored_works":69},{"name":"Lauren Elizabeth Colbert","coauthored_works":57}],"source":"works"},"recognition":{"education":{"total":3,"shown":3,"rows":[{"value":"Board certification: American Board of Radiology, 2007","source_url":"https://faculty.mdanderson.org/profiles/lilie_lin.html","status":"verified","collected_at":"2026-10-28"},{"value":"MD, Washington University in St. Louis, 2001","source_url":"https://faculty.mdanderson.org/profiles/lilie_lin.html","status":"verified","collected_at":"2026-10-28"},{"value":"BA, Biochemistry, Washington University in St. Louis, 1997","source_url":"https://faculty.mdanderson.org/profiles/lilie_lin.html","status":"verified","collected_at":"2026-10-28"}]},"roles":{"total":8,"shown":3,"rows":[{"value":"Section Chief, Radiation Oncology, MD Anderson Cancer Center (2026-present)","source_url":"https://faculty.mdanderson.org/profiles/lilie_lin.html","status":"verified","collected_at":"2026-10-28"},{"value":"Associate Medical Director, Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center (2022-2026)","source_url":"https://faculty.mdanderson.org/profiles/lilie_lin.html","status":"verified","collected_at":"2026-10-28"},{"value":"Scientific Review Panel, ASTRO (2024-present)","source_url":"https://faculty.mdanderson.org/profiles/lilie_lin.html","status":"verified","collected_at":"2026-10-28"}]},"awards":{"total":1,"shown":1,"rows":[{"value":"Ruby E. Rutherford Distinguished Professorship, The University of Texas MD Anderson Cancer Center (2024)","source_url":"https://faculty.mdanderson.org/profiles/lilie_lin.html","status":"verified","collected_at":"2026-10-28"}]},"media":{"total":1,"shown":1,"rows":[{"value":"Podcast episode, International Journal of Gynecologic Cancer (IJGC) BMJ podcast: radiotherapy and novel agents in gynecologic cancers, with Lilie Lin (March 31, 2020)","source_url":"https://ijgcbmj.podbean.com/e/radiotherapy-and-novel-agents-in-gynecologic-cancers-with-lilie-lin-1684257976","status":"provisional","collected_at":"2026-10-28"}]}},"similar":[{"name":"Hagop Kantarjian","slug":"hagop-kantarjian","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hagop-kantarjian","json_url":"https://www.findmykol.com/kol/hagop-kantarjian/profile.json"},{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Jaffer Ajani","slug":"jaffer-ajani","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jaffer-ajani","json_url":"https://www.findmykol.com/kol/jaffer-ajani/profile.json"},{"name":"Funda Meric-Bernstam","slug":"funda-meric-bernstam","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Surgery","url":"https://www.findmykol.com/kol/funda-meric-bernstam","json_url":"https://www.findmykol.com/kol/funda-meric-bernstam/profile.json"},{"name":"Baha Sibai","slug":"baha-sibai","institution":"McGovern Medical School at UTHealth Houston","specialty":"Maternal & Fetal Medicine","url":"https://www.findmykol.com/kol/baha-sibai","json_url":"https://www.findmykol.com/kol/baha-sibai/profile.json"},{"name":"Robert Coleman","slug":"robert-coleman","institution":"Vaniam Group","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/robert-coleman","json_url":"https://www.findmykol.com/kol/robert-coleman/profile.json"},{"name":"Kathleen Moore","slug":"kathleen-moore","institution":"University of Nebraska Medical Center","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/kathleen-moore","json_url":"https://www.findmykol.com/kol/kathleen-moore/profile.json"},{"name":"Bradley Monk","slug":"bradley-monk","institution":"Florida Cancer Specialists & Research Institute","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/bradley-monk","json_url":"https://www.findmykol.com/kol/bradley-monk/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":10,"payments":1,"funding":13,"congress":40,"publications":8,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-28"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-28"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2023 to 2024","collected_at":"2026-10-28"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-10-28"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-28"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-28"}},"methodology_url":"https://www.findmykol.com/about#methodology"}